SARS-CoV-2 and its ACE2 receptor

The SARS-CoV-2 virus enters the human host cell via the receptor ACE2 and uses the serine protease TMPRSS2 for S protein priming. The ACE2 usage has been shown to be crucial for transmissibility of other coronaviruses. Much research into the COVID-19 pandemic focuses on understanding the complex process of virus entry.

May 26, 2020
Review

Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review

Life Sciences
KaviyarasiRenuV G Abilash
May 27, 2020
Open Access

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Nature
Bin JuLinqi Zhang
May 24, 2020
ReviewOpen Access

A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2

The FEBS Journal
Cassandra L AtzrodtThomas P Clements
May 27, 2020
Open Access

SARS-CoV-2 strategically mimics proteolytic activation of human ENaC

ELife
Praveen AnandVenky Soundararajan
May 24, 2020

Sodium status and kidney involvement during COVID-19 infection

Virus Research
Adrian PostStephan J L Bakker
May 26, 2020
Open Access

Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication

The Tohoku Journal of Experimental Medicine
Mutsuo YamayaRyoichi Nagatomi
May 25, 2020
ReviewOpen Access

COVID-19 and the nervous system

Journal of Neurovirology
Joseph R Berger
May 28, 2020
ReviewOpen Access

Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19

Journal of Cardiovascular Translational Research
Marat FudimLuis Ulloa
May 25, 2020
Open Access

Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - the "Gabrin sign"

Journal of the American Academy of Dermatology
Carlos Gustavo WambierAndy Goren

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/sars-cov-2-and-its-ace2-receptor/a267603a-5313-41ce-9de1-5b8c2eb4709b